A Stockholm-based health technology company called Neko Health announced Wednesday that it has secured $700 million in a Series C funding round, setting the stage for the opening of its first clinic in the United States later this year.
The funding round was led by U.S. venture capital firm Lightspeed Venture Partners and co-led by O.G. Venture Partners, according to a company statement. Existing investors Atomico, General Catalyst, and Lakestar also took part in the round, joined by new backers including Liberty City Ventures, Positive Sum, and BDT & MSD, a merchant bank backed by Michael Dell.
Neko Health’s clinics provide a comprehensive scan that evaluates a range of health indicators, including skin conditions such as moles and marks, blood sugar levels to flag pre-diabetes risk, blood abnormalities, and risk factors associated with metabolic syndrome, stroke, and heart attack.
The full assessment takes approximately 60 minutes and captures millions of individual health data points. The service is currently priced at £299 (roughly $400) in Britain and 2,750 Swedish crowns (approximately $286) in Sweden.
Neko Health was co-founded in 2018 by Hjalmar Nilsonne and Spotify boss Daniel Ek.
